|
Japan Medical Dynamic Marketing, INC. is a medical device company focused on the orthopedic field. The group engages in the import, development, manufacturing, and sales of orthopedic medical devices. Its primary business involves the distribution of bone fixation materials, artificial joints, and spinal fixation devices in the Japanese market. The company sources these products from domestic and international manufacturers as well as its US subsidiary, ODEV. ODEV develops and manufactures these orthopedic devices and supplies them to the parent company while also independently selling artificial joints and spinal fixation devices primarily in the United States. Summarised from the annual report, fiscal year ended Mar 2026 |
Industry Medical Devices | Homepage jmdm.co.jp |
| Sector Healthcare | IR page jmdm.co.jp | |
|
Tags
orthopedic devices, bone fixation materials, artificial joints, spinal fixation devices, medical device distribution, medical device manufacturing, ODEV
|
Press page jmdm.co.jp/pressrelease |
Metrics
| Valuation | |
|---|---|
| Market cap | ¥ 16.865B |
| Market cap (USD) | $ 105.408M |
| P/E | -10.79 |
| PEG | — |
| P/BV | 0.73 |
| P/S | 0.74 |
| P/OCF | 20.82 |
| P/FCF | -12.95 |
| Dividend yield | 2.7% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 1.0% |
| ROI | 0.85% |
| ROIC | 1.0% |
| Profit margin | 1.1% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -43.0% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 1 |
| Quality score | -55.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.917B | 25.114B | 23.178B | 21.308B | 19.193B | 16.738B | 18.083B | 16.729B | 14.808B | 13.63B | 13.025B | 11.855B | 9.459B | 8.134B |
| Net profit | 263.138M | -461.798M | 1.272B | 1.424B | 2.136B | 1.665B | 2.165B | 1.985B | 1.425B | 1.131B | 800.546M | -391.528M | 286.656M | -397.894M |
| Free cash flow | -1.792B | -504.096M | 302.451M | 870.673M | 1.527B | 1.228B | 945.598M | 273.508M | 1.546B | 961.096M | -28.971M | — | — | — |
| Figure | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 537 | 569.33 | 735.09 | 1.041K | 1.636K | 2.265K | 1.634K | 1.083K | 993.94 | 777.78 | 607.53 | 302.06 | 302.06 | — |
| Price performance 12m | -0.06 | -0.23 | -0.29 | -0.36 | -0.28 | 0.39 | 0.51 | 0.09 | 0.28 | 0.28 | 1.01 | 0 | — | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (JPY) | 3.96B | 4.41B | 4.58B | 4.43B | 4.48B | 10.4B | 10.5B | 11.8B | 12.3B | 10.5B |
| ↳ YoY growth | +21.7% | +11.2% | +3.8% | -3.2% | +1.1% | +132.8% | +1.1% | +12.2% | +3.6% | -14.6% |
| ↳ 5y CAGR | +6.6% | +21.3% | +19.1% | +20.9% | +22.6% | +18.5% | ||||
| Borrowings, current (JPY) | 4.54B | 3.68B | 2.89B | 1.69B | 998M | 557M | 1.05B | 1.16B | 3.14B | 4.89B |
| Borrowings, non-current (JPY) | 1.4B | 710M | 1.52B | 2.34B | 2.02B | 1.25B | 732M | 260M | 110M | 766M |
| Lease liabilities (JPY) | 289M | 194M | 127M | 103M | 70.6M | 44M | 92.7M | 72.2M | 34.2M | 219M |
| Cash and deposits (JPY) | 2.79B | 2.46B | 2.26B | 2.51B | 2.47B | 2.59B | 2.8B | 2.32B | 3.18B | 3.11B |
| Intangible assets (JPY) | 102M | 85.6M | 182M | 282M | 254M | 292M | 263M | 219M | 430M | 430M |
| Net debt (borrowings + leases - cash) (JPY) | 3.44B | 2.13B | 2.27B | 1.62B | 623M | -742M | -933M | -827M | 104M | 2.76B |
| Cash flow detail | ||||||||||
| Operating cash flow (JPY) | 2.04B | 2.56B | 2.37B | 2.73B | 2.6B | 3.11B | 2.19B | 2.1B | 1.05B | 206M |
| Purchases of property, plant and equipment (JPY) | -1.06B | -1B | -1.98B | -1.65B | -1.35B | -1.54B | -1.22B | -1.78B | -1.55B | -1.96B |
| Purchases of intangible assets (JPY) | -20.7M | -15.7M | -116M | -131M | -23.7M | -47M | -93.2M | -19.3M | -116M | -36.7M |
| Change in receivables (cash effect) (JPY) | -581M | -484M | -136M | 118M | -30.9M | -662M | 11M | -438M | -98.5M | 913M |
| Change in inventories (cash effect) (JPY) | -312M | 92M | -1.12B | -1.03B | -411M | -224M | -1.01B | -458M | -1.13B | -1.54B |
| Change in payables (cash effect) (JPY) | -28.9M | 191M | 296M | -137M | -126M | 253M | 155M | 282M | -81.9M | 53.9M |
| Dividends paid (cash effect) (JPY) | -159M | -185M | -211M | -238M | -264M | -290M | -317M | -344M | -371M | -397M |
| Share buybacks (cash effect) (JPY) | -52M | -188,000 | -23,000 | -35M | -279,000 | -401,000 | -90.9M | -152,000 | -82,000 | -6,000 |
| Interest paid (cash effect) (JPY) | -115M | -79M | -28.4M | -88.9M | -42.4M | -34.3M | -17.9M | -29.2M | -50.8M | -195M |
| Income taxes paid (cash effect) (JPY) | -220M | -300M | -215M | -322M | -329M | -474M | -583M | -893M | -669M | 6.2M |
| Operating cash flow before change in receivables (JPY) | 2.62B | 3.05B | 2.5B | 2.61B | 2.63B | 3.77B | 2.18B | 2.54B | 1.15B | -708M |
| Free cash flow (OCF - PPE - intangibles) (JPY) | 961M | 1.55B | 274M | 946M | 1.23B | 1.53B | 871M | 302M | -620M | -1.79B |
| Income detail | ||||||||||
| Research and development expense (JPY) | 480M | 595M | 484M | 471M | 467M | 486M | 663M | 874M | 959M | 864M |
| ↳ 5y CAGR | -0.4% | +0.2% | +2.2% | +12.5% | +15.3% | +13.1% | ||||
| Total comprehensive income (JPY) | 1.17B | 1.16B | 2.18B | 2.03B | 1.98B | 3.07B | 2.21B | 2.69B | -479M | 1.09B |
| Comprehensive income to owners (JPY) | 1.16B | 1.15B | 2.17B | 2.01B | 1.97B | 3.05B | 2.18B | 2.66B | -466M | 1.08B |
| Provision for credit losses (JPY) | 223,000 | 1.16M | 366,000 | 3.56M | -11.2M | -704,000 | -28,000 | 2.61M | 1.87M | 254,000 |
| Credit cost ratio (credit losses / average receivables) (%) | 0.0% | 0.0% | 0.0% | 0.1% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Reported | Jun 26, 2017 | Jun 25, 2018 | Jun 25, 2019 | Jun 23, 2020 | Jun 22, 2021 | Jun 28, 2022 | Jun 27, 2023 | Jun 25, 2024 | Jun 25, 2025 | Jun 18, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpTimely disclosures published on TDnet, newest first, titles as filed in Japanese. The link opens the disclosure on TDnet. Filings with EDINET (periodic reports, extraordinary reports, offerings, holding and buy-back reports), newest first, titles as filed in Japanese. The link opens the filing on EDINET. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Japan Medical Dynamic Marketing, INC.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.







